XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 7, 2024 | (Q2)Jun 15, 2024 | (Q1)Mar 23, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 9, 2023 | (Q2)Jun 17, 2023 | (Q1)Mar 25, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -6.96%12.51B | 8.17%6.29B | -12.58%4.91B | -2.28%2.36B | -165.56%-1.04B | 24.34%13.44B | 29.01%5.81B | 26.80%5.61B | 17.32%2.41B | -125.29%-392M |
Net income from continuing operations | 5.14%9.63B | 15.86%1.53B | -5.49%2.95B | 11.66%3.09B | 5.61%2.05B | 1.97%9.16B | 147.48%1.32B | 14.39%3.12B | 91.63%2.77B | -54.51%1.94B |
Operating gains losses | 176.00%414M | 426.32%300M | 51.61%47M | 12.50%36M | 3.33%31M | 105.17%150M | -69.02%57M | -71.82%31M | -74.80%32M | 100.90%30M |
Depreciation and amortization | 8.44%3.82B | 8.44%1.26B | 6.90%899M | 9.75%889M | 8.78%768M | 7.26%3.52B | 7.50%1.16B | 7.54%841M | 6.58%810M | 7.29%706M |
Deferred tax | 164.94%176M | 108.47%52M | -124.66%-18M | -86.46%26M | 48.72%116M | 65.57%-271M | -11.43%-614M | 125.61%73M | 192.31%192M | -69.65%78M |
Other non cash items | -477.63%-439M | -167.43%-147M | 241.05%134M | -101.72%-234M | -131.33%-192M | 86.31%-76M | 12.95%218M | 59.05%-95M | 51.46%-116M | 70.04%-83M |
Change In working capital | -403.26%-1.7B | -0.87%2.4B | -49.65%781M | 17.17%-965M | -24.40%-3.92B | 62.05%-337M | 104.21%2.42B | 25.49%1.55B | -18.15%-1.17B | -35.35%-3.15B |
-Change in receivables | 82.60%-138M | 52.65%1.38B | -3.79%-383M | -6.11%-1.04B | 72.41%-96M | 55.02%-793M | 83.03%906M | 26.93%-369M | -7.21%-982M | 58.42%-348M |
-Change in inventory | -20.31%-314M | -16.04%178M | -46.03%204M | -31.07%-405M | 46.31%-291M | 77.15%-261M | 169.51%212M | 147.06%378M | 29.93%-309M | 1.28%-542M |
-Change in prepaid assets | 407.69%40M | 4.80%240M | 468.97%165M | -235.29%-23M | -18.75%-342M | -111.02%-13M | -5.37%229M | -53.23%29M | 325.00%17M | -51.58%-288M |
-Change in payables and accrued expense | -275.89%-1.28B | -44.10%602M | -47.46%795M | 363.30%505M | -61.81%-3.19B | -61.56%730M | 42.65%1.08B | -0.85%1.51B | -70.30%109M | -162.88%-1.97B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -6.96%12.51B | 8.17%6.29B | -12.58%4.91B | -2.28%2.36B | -165.56%-1.04B | 24.34%13.44B | 29.01%5.81B | 26.80%5.61B | 17.32%2.41B | -125.29%-392M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0.42%-5.47B | 19.54%-2.51B | -58.05%-1.51B | -0.11%-892M | -5.64%-562M | -126.13%-5.5B | -13.76%-3.12B | 48.68%-956M | -13.79%-891M | -118.00%-532M |
Capital expenditure reported | 3.62%-5.32B | 17.21%-2.47B | -12.21%-1.15B | -16.63%-1.09B | -5.68%-614M | -5.97%-5.52B | -12.45%-2.98B | 3.12%-1.02B | 4.61%-932M | -11.30%-581M |
Net PPE purchase and sale | 72.73%342M | 146.27%165M | 455.56%50M | 16.50%120M | -63.16%7M | -21.12%198M | 191.30%67M | 50.00%9M | -52.97%103M | 533.33%19M |
Net business purchase and sale | 62.34%-90M | -12.09%-204M | 118.37%9M | 175.32%58M | -31.88%47M | -109.08%-239M | -420.00%-182M | 93.68%-49M | -1,183.33%-77M | -98.00%69M |
Net investment purchase and sale | -2,725.00%-420M | 105.26%1M | -563.74%-422M | 58.82%-7M | 120.51%8M | 113.68%16M | 76.25%-19M | 302.22%91M | -21.43%-17M | -277.27%-39M |
Net other investing changes | -70.83%14M | 0.00%-1M | -94.12%1M | --24M | ---10M | 336.36%48M | -125.00%-1M | 112.50%17M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 0.42%-5.47B | 19.54%-2.51B | -58.05%-1.51B | -0.11%-892M | -5.64%-562M | -126.13%-5.5B | -13.76%-3.12B | 48.68%-956M | -13.79%-891M | -118.00%-532M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -151.11%-7.56B | 25.27%-2.27B | -263.11%-2.38B | -3,244.83%-2.91B | -98.71%10M | 64.70%-3.01B | -4.36%-3.04B | 55.53%-656M | 96.30%-87M | 143.65%777M |
Net issuance payments of debt | -85.43%695M | 83.35%-168M | -117.87%-248M | -148.17%-854M | -24.94%1.97B | 688.89%4.77B | -5.77%-1.01B | 144.80%1.39B | 569.05%1.77B | 5,917.78%2.62B |
Net common stock issuance | 0.00%-1B | 3.61%-240M | -0.34%-299M | -7.51%-315M | 8.75%-146M | 33.33%-1B | 27.62%-249M | 34.79%-298M | 42.09%-293M | 17.10%-160M |
Cash dividends paid | -8.19%-7.23B | -6.84%-1.86B | -6.95%-1.86B | -9.30%-1.74B | -9.89%-1.77B | -8.26%-6.68B | -9.77%-1.74B | -9.63%-1.74B | -6.64%-1.59B | -6.84%-1.61B |
Proceeds from stock option exercised by employees | 43.10%166M | 75.00%28M | 121.43%31M | 2.50%41M | 43.48%66M | -15.94%116M | -36.00%16M | -41.67%14M | 0.00%40M | -6.12%46M |
Net other financing activities | 11.74%-188M | 43.33%-34M | 83.33%-3M | -168.75%-43M | 9.24%-108M | -18.99%-213M | -5.26%-60M | 10.00%-18M | 0.00%-16M | -38.37%-119M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -151.11%-7.56B | 25.27%-2.27B | -263.11%-2.38B | -3,244.83%-2.91B | -98.71%10M | 64.70%-3.01B | -4.36%-3.04B | 55.53%-656M | 96.30%-87M | 143.65%777M |
Net cash flow | ||||||||||
Beginning cash position | 91.39%9.76B | -27.52%7.34B | 2.82%6.42B | 68.08%8.13B | 91.39%9.76B | -10.64%5.1B | 55.43%10.13B | 12.57%6.24B | -27.71%4.84B | -10.64%5.1B |
Current changes in cash | -110.55%-521M | 534.01%1.51B | -74.69%1.01B | -200.91%-1.45B | -983.67%-1.59B | 3,577.46%4.94B | 69.83%-347M | 267.89%4B | 232.69%1.43B | -114.69%-147M |
Effect of exchange rate changes | -148.01%-687M | -1,186.96%-296M | 20.91%-87M | -850.00%-266M | 67.24%-38M | 40.43%-277M | 91.42%-23M | 3.51%-110M | 57.58%-28M | -582.35%-116M |
End cash Position | -12.38%8.55B | -12.38%8.55B | -27.52%7.34B | 2.82%6.42B | 68.08%8.13B | 91.39%9.76B | 91.39%9.76B | 55.43%10.13B | 12.57%6.24B | -27.71%4.84B |
Free cash flow | -9.28%7.19B | 34.90%3.82B | -18.12%3.76B | -14.20%1.27B | -70.09%-1.66B | 41.40%7.92B | 52.70%2.83B | 36.19%4.59B | 37.20%1.48B | -39.80%-973M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |